<?xml version="1.0" encoding="UTF-8"?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
  <PMID Version="1">1000091</PMID>
  <DateCreated>
    <Year>1977</Year>
    <Month>02</Month>
    <Day>24</Day>
  </DateCreated>
  <DateCompleted>
    <Year>1977</Year>
    <Month>02</Month>
    <Day>24</Day>
  </DateCompleted>
  <DateRevised>
    <Year>2009</Year>
    <Month>11</Month>
    <Day>11</Day>
  </DateRevised>
  <Article PubModel="Print">
    <Journal>
      <ISSN IssnType="Print">0007-4551</ISSN>
      <JournalIssue CitedMedium="Print">
        <Volume>63</Volume>
        <Issue>3</Issue>
        <PubDate>
          <MedlineDate>1976 Jul-Sep</MedlineDate>
        </PubDate>
      </JournalIssue>
      <Title>Bulletin du cancer</Title>
      <ISOAbbreviation>Bull Cancer</ISOAbbreviation>
    </Journal>
    <ArticleTitle>Combined modality approach in small cell carcinoma of the bronchus. A pilot study.</ArticleTitle>
    <Pagination>
      <MedlinePgn>387-92</MedlinePgn>
    </Pagination>
    <Abstract>
      <AbstractText>Our first experiences with polychemotherapy (COMB-regimen) followed by radiotherapy for patients with small cell carcinomas are encouraging. 7 patients out of 18 showed a complete remission. The treatment was well tolerated by all patients.</AbstractText>
    </Abstract>
    <AuthorList CompleteYN="Y">
      <Author ValidYN="Y">
        <LastName>Scherer</LastName>
        <ForeName>E</ForeName>
        <Initials>E</Initials>
      </Author>
      <Author ValidYN="Y">
        <LastName>Mamoski</LastName>
        <ForeName>H B</ForeName>
        <Initials>HB</Initials>
      </Author>
      <Author ValidYN="Y">
        <LastName>Schmidt</LastName>
        <ForeName>C G</ForeName>
        <Initials>CG</Initials>
      </Author>
      <Author ValidYN="Y">
        <LastName>Osieka</LastName>
        <ForeName>R</ForeName>
        <Initials>R</Initials>
      </Author>
    </AuthorList>
    <Language>eng</Language>
    <PublicationTypeList>
      <PublicationType>Journal Article</PublicationType>
    </PublicationTypeList>
  </Article>
  <MedlineJournalInfo>
    <Country>FRANCE</Country>
    <MedlineTA>Bull Cancer</MedlineTA>
    <NlmUniqueID>0072416</NlmUniqueID>
    <ISSNLinking>0007-4551</ISSNLinking>
  </MedlineJournalInfo>
  <ChemicalList>
    <Chemical>
      <RegistryNumber>0</RegistryNumber>
      <NameOfSubstance>Antineoplastic Agents</NameOfSubstance>
    </Chemical>
  </ChemicalList>
  <CitationSubset>IM</CitationSubset>
  <MeshHeadingList>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
      <QualifierName MajorTopicYN="N">adverse effects</QualifierName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Bronchial Neoplasms</DescriptorName>
      <QualifierName MajorTopicYN="N">drug therapy</QualifierName>
      <QualifierName MajorTopicYN="N">radiotherapy</QualifierName>
      <QualifierName MajorTopicYN="Y">therapy</QualifierName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Carcinoma</DescriptorName>
      <QualifierName MajorTopicYN="N">drug therapy</QualifierName>
      <QualifierName MajorTopicYN="N">radiotherapy</QualifierName>
      <QualifierName MajorTopicYN="Y">therapy</QualifierName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Leukocyte Count</DescriptorName>
    </MeshHeading>
    <MeshHeading>
      <DescriptorName MajorTopicYN="N">Pilot Projects</DescriptorName>
    </MeshHeading>
  </MeshHeadingList>
</MedlineCitation>